Health and Wellness : EBOLA: an experiment in US bio-terrorism?

Discussion in 'Black Health and Wellness' started by writer33, Oct 22, 2014.

  1. writer33

    writer33 Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Mar 3, 2014
    Messages:
    209
    Likes Received:
    80
    Gender:
    Male
    Ratings:
    +85
    I haven't been here for a while, but felt this is worth sharing. I posted this on Facebook this past Saturday:

    A report I received yesterday from Global Research gave me a nauseous feeling, similar to an article in the 1990’s by Dr. William Campbell Douglas that was titled, “WHO Killed Africa.”

    It is not a question. WHO is the World Health Organization, and the article talked about how the AIDs virus, artificially developed by the US Army’s Biological Warfare Laboratory in Ft. Detrick, Md, was spread in parts of Africa under a fraudulent WHO smallpox (or other known diseases) inoculation program that, unknown to those who were vaccinated, also contained the AIDs virus.

    Portions of Africa, and certain predominantly black communities in the US, including those in San Francisco and a few other major US cities were infected, followed by outbreaks that could be blamed as coming from primarily the gay communities.

    That’s how the AIDs epidemic was typically characterized.

    Saturday’s (Oct 18) Global Research report seems to follow a similar theme.

    “Is it possible that the United States Department of Defense (DOD) and other Western countries are directly responsible for infecting Africans with the Ebola virus?” it asks.

    Dr. Cyril Broderick, A Liberian scientist and a former professor of Plant Pathology at the University of Liberias College of Agriculture and Forestry says the West, particularly the U.S. is responsible for the Ebola outbreak in West Africa. Dr. Broderick claims the following in an exclusive article published in the Daily Observer based in Monrovia, Liberia. He wrote the following:

    “The US Department of Defense (DoD) is funding Ebola trials on humans, trials which started just weeks before the Ebola outbreak in Guinea and Sierra Leone.”

    “The reports continue and state that the DoD gave a contract worth $140 million dollars to Tekmira, a Canadian pharmaceutical company, to conduct Ebola research. This research work involved injecting and infusing healthy humans with the deadly Ebola virus. Hence, the DoD is listed as a collaborator in a First in Human Ebola clinical trial (NCT02041715), which started in January 2014 shortly before an Ebola epidemic was declared in West Africa in March.”

    Dr. Broderick claims that the U.S. government has a research laboratory located in a town called Kenema in Sierra Leone that studies what he calls viral fever bioterrorism, It is also the town where he acknowledges that is the epicentre of the Ebola outbreak in West Africa.

    “He also asks an important question when he says,“It is most disturbing that the U. S. Government has been operating a viral hemorrhagic fever bioterrorism research laboratory in Sierra Leone. Are there others?”

    “After all,” he notes, “the U.S. government has been experimenting with deadly diseases on human beings for a long time, history tells us so.”

    One example, he cites, is Guatemala. Between 1946 and 1948, the United States government under President Harry S. Truman in collaboration with Guatemalan President Juan José Arévalo and his health officials deliberately infected more than 1500 soldiers, prostitutes, prisoners and even mental patients with syphilis and other sexually transmitted diseases such as gonorrhea and chancroid (a bacterial sexual infection) out of more than 5500 Guatemalan people who participated in the experiments.

    The worst part of it is that none of the test subjects infected with the diseases ever gave informed consent.

    The Boston Globe published the discovery made by Medical historian and professor at Wellesley College, Susan M. Reverby in 2010 called,“Wellesley professor unearths a horror: Syphilis experiments in Guatemala.”

    After Reverby’s discovery, the Obama administration apparently gave an apology to then-President Alvaro Colom according to the Boston Globe. Obama called President Álvaro Colom Caballeros of Guatemala to apologize, and Obama’s spokesman told reporters the experiment was tragic, and the United States by all means apologizes to all those who were impacted by this.

    Secretary of State Hillary Rodham Clinton had called Colom to break the news to him. In her conversation with the Guatemalan president, Clinton expressed her personal outrage and deep regret that such reprehensible research could occur, said Arturo Valenzuela, assistant secretary of state for Western Hemisphere affairs.

    The study in Guatemala was led by John Cutler, a US health service physician who also took part in the controversial Tuskegee Syphilis experiments which began in the 1930s.

    Said Global Research:

    "Washington’s reaction to the report is a farce. The apology made to Guatemalas government was for the sake of public relations. Washington knows about its human experimentations in the past with deadly diseases conducted by government-funded laboratories that are known to be harmful to the public."

    It went on to say the U.S. government admitted to its wrongdoing, 62 years too late.

    The challenge is global, and we request assistance from everywhere, including China, Japan, Australia, India, Germany, Italy, and even kind-hearted people in the U.S., France, the U.K., Russia, Korea, Saudi Arabia, and anywhere else whose desire is to help. The situation is bleaker than we on the outside can imagine, and we must provide assistance however we can.

    Global Research continued:

    "US government agencies have a long history of carrying out allegedly defensive biological warfare research at labs in Liberia and Sierra Leone. This includes the Centers for Disease Control and Prevention (CDC), which is now the point agency for managing the Ebola spill-over into the US," Prof. Francis Boyle said.

    Then he asks: "Why has the Obama administration dispatched troops to Liberia when they have no training to provide medical treatment to dying Africans? How did Zaire/Ebola get to West Africa from about 3,500km away from where it was first identified in 1976?"

    I have a follow-up report that is more troubling, pertaining to US complicity in biological warfare research and development.
     
  2. writer33

    writer33 Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Mar 3, 2014
    Messages:
    209
    Likes Received:
    80
    Gender:
    Male
    Ratings:
    +85
    Then this update:

    Sunday I posted a Global Research report that spoke of US complicity in bio-warfare clinical trials. Part of that report:

    "The reports continue and state that the DoD gave a contract worth $140 million dollars to Tekmira, a Canadian pharmaceutical company, to conduct Ebola research. This research work involved injecting and infusing healthy humans with the deadly Ebola virus. Hence, the DoD is listed as a collaborator in a First in Human Ebola clinical trial (NCT02041715), which started in January 2014 shortly before an Ebola epidemic was declared in West Africa in March.”

    Dr. Broderick claims that the U.S. government has a research laboratory located in a town called Kenema in Sierra Leone that studies what he calls viral fever bioterrorism, It is also the town where he acknowledges that is the epicentre of the Ebola outbreak in West Africa.

    “He also asks an important question when he says, “It is most disturbing that the U. S. Government has been operating a viral hemorrhagic fever bioterrorism research laboratory in Sierra Leone. Are there others?”

    Now some further corroboration, this from former Reagan Administration cabinet official Dr. Paul Craig Roberts.

    Is the US government the master criminal of our time?

    Experts have brought to the public's attention that ebola is a genetically modified organism developed in US biowarfare laboratories in Africa.

    In two articles reproduced from Tom Feeley's Information Clearing House (a good site worthy of your support), Dr. Francis Boyle of the University of Illinois and Dr. Cyril Broderick of the University of Liberia and the University of Delaware provide their fact-based assessments. Dr. Boyle drafted the Biological Weapons Anti-Terrorism Act of 1989, the US implementing legislation for the 1972 Biological Weapons Convention.

    All of this is indeed very disturbing….

    Roberts makes a further observation: "For speaking out, both Boyle and Broderick will be viciously attacked by the US print and TV media. Remember the case of Gary Webb who exposed the CIA's drug-running that supported the Contras in Nicaragua. The cocaine that launched the War on Drugs was brought in by the CIA.

    This is a subject referring to the new movie, "Kill the Messenger," that tells how the mainstream media literally crucified Webb's investigative work. And I have little respect for the "national security" nonsense that is claimed to protect Americans which I see, instead, as a cover-your-*** mentality to protect the government, not us.

    URL to the entire article:

    http://www.opednews.com/articles/Is...iminally-Complict_Death_Ebola-141020-375.html
     
  3. Clyde C Coger Jr

    Clyde C Coger Jr going above and beyond PREMIUM MEMBER

    Country:
    United States
    Joined:
    Nov 17, 2006
    Messages:
    39,362
    Likes Received:
    10,419
    Gender:
    Male
    Occupation:
    Speaker/Teacher/Author
    Location:
    Dallas, TX
    Home Page:
    Ratings:
    +12,074
    ...


    You are a little tardy to the party with this information writer33, but glad to see ya:


    Ebola Pandemic: Points 2 Red Cross (and many others...)
    Discussion in 'Black People Open Forum' started by Fine1952, Saturday at 10:35 PM

    http://destee.com/index.php?threads...-red-cross-and-many-others.81839/#post-900236

     
  4. Fine1952

    Fine1952 Happy Winter Solstice MEMBER

    Country:
    United States
    Joined:
    Sep 27, 2005
    Messages:
    7,221
    Likes Received:
    2,241
    Gender:
    Female
    Ratings:
    +2,777
    Why should anyone be shocked? YT in his bold arrogance has written down exactly how he plans to exterminate people of colour

    [​IMG]
     
  5. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Western countries is one way to say it...


    Meet the Face of Ebola and possibly AIDS?

    Ebola Watch: The Gambia, Nigeria, and Mali




    Here's more...


    http://clinicaltrials.gov/show/NCT02041715




    NOW FOLLOW THE TIME LINE...



    January 14, 2014
    Tekmira Doses First Subject in Human Clinical Trial of TKM-Ebola


    VANCOUVER, British Columbia, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that it has dosed the first subject in a Phase I human clinical trial of TKM-Ebola, an anti-Ebola viral therapeutic that is being developed under a US$140 million contract with the U.S. Department of Defense.


    http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=819313


    Doctors Without Borders to Vaccinate 400,000 Children Against Measles in Guinea

    Conakry, Guinea/New York, February 10, 2014—Medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a campaign to vaccinate close to 400,000 children in Conakry, Guinea, against measles in the next three weeks. To date, there are 1,105 suspected cases, with 68 confirmed cases in the region, causing fear of a rapid explosion in the number of infections.

    “Measles is one of the most highly contagious diseases, and it can spread like wildfire,” said Corinne Benazech, MSF’s Head of Mission in Conakry. “It affects primarily children, and can involve severe medical complications so it is critical that action be taken in order to avoid the catastrophe that occurred in 2009, when ten children lost their lives.”

    Working in co-operation with the Ministry of Health, MSF has deployed 32 teams throughout the Matam, Matoto and Ratoma neighbourhoods of Conakry. The Guinean government announced that its measles vaccine supply will be exhausted by February 15. It has asked for MSF support in organizing the emergency vaccination campaign in the three communities where an epidemic was declared last month.


    http://www.doctorswithoutborders.or...cinate-400000-children-against-measles-guinea



    Guinea: “people forget that you can still die from measles”

    Guinea / February 24, 2014

    [​IMG]
    A girl receives a measles vaccination from Médecins Sans Frontières in Guinea, where just over half of Guinean children have been vaccinated against measles © Ikram N'gadi/MSF

    Last Saturday, Médecins Sans Frontières launched a measles vaccination campaign in Conakry, the capital of Guinea, following the January 14 official declaration of an epidemic. Médecins Sans Frontières plans to vaccinate close to 500,000 children between the ages of 6 months to 10 years over a two-week period.



    http://www.msf.org.au/from-the-fiel...rget-that-you-can-still-die-from-measles.html



    March 5, 2014
    Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic


    VANCOUVER, British Columbia, March 5, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of TKM-Ebola, an anti-Ebola viral therapeutic.

    The FDA's Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important new drugs to the patient earlier. Fast Track addresses a broad range of serious conditions.1

    "This is an important milestone for Tekmira and our TKM-Ebola program. Receiving a Fast Track designation from the FDA supports our work to advance the development of this therapeutic as quickly as possible. Our leadership in developing anti-viral therapies has been supported by our collaboration with the U.S. Department of Defense, which is funding the development of TKM-Ebola," said Dr. Mark J. Murray, Tekmira's President and CEO.


    http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=830680


    UTMB gets millions to study Ebola in antiterrorism effort

    Mar 6, 2014, 2:26pm CST

    [​IMG]

    University of Texas Medical Branch, Galveston, Texas
    UTMB is receiving millions of dollars to develop a vaccine for the deadly Ebola (picture here) and Marburg viruses.

    The University of Texas Medical Branch at Galveston was awarded funds that it will use toward fighting bioterrorism.

    UTMB, Maryland-based Profectus Biosciences Inc., Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) of British Columbia and the Vanderbilt University Medical Center received up to $26 million by the National Institutes of Health to advance treatments of the highly lethal hemorrhagic fever viruses known as Ebola and Marburg.

    http://www.bizjournals.com/houston/...millions-to-study-ebola-in-antiterrorism.html


    • Texas - Take Note


    Canada probes possible Ebola case
    By Dana Ford, CNN
    March 25, 2014

    (CNN) -- Health officials in Canada said Monday they are looking into the case of a man who recently traveled from Liberia and is exhibiting symptoms consistent with viral hemorrhagic fevers.

    Viral hemorrhagic fevers is a generic term that refers to a number of diseases found in Africa, including Ebola hemorrhagic fever, Lassa fever, Crimean-Congo hemorrhagic fever and yellow fever, according to Denise Werker, deputy chief medical health officer at the Saskatchewan Ministry of Health.

    "There is no risk to the general public at all about this incident. We recognize that there's going to be a fair amount of concern, and that's why we wanted to go public with this as soon as possible and dispel some of those myths that are out there," she told reporters Monday.

    "We do not have information that it's Ebola hemorrhagic fever. All we know at this point is that we have a person who's critically ill who traveled from a country where these diseases occur," Werker said.

    An Ebola outbreak has killed at least 59 people in Guinea, which borders Liberia in West Africa.

    Werker said the Canadian patient is in an intensive care unit and isolated, meaning no visitors are allowed. Specimens have been sent for study, and officials are expecting preliminary results Tuesday, she said.


    http://www.cnn.com/2014/03/24/health/canada-possible-ebola-case/



    Ebola Cure In The Works As Outbreak Death Toll Jumps To 80, Spread Called Unprecedented

    March 31, 2014

    [​IMG]
    ***Interesting reaction from this "worker", doesn't care for the camera?***

    An Ebola cure was fast-tracked by the U.S. government earlier this month, but it will not come in time to help ease the West African outbreak that is now being called unprecedented in its scale. A new report from heath authorities in Guinea where the outbreak began and is centered, now puts the confirmed Ebola death toll at 78, up from 70 over the weekend, with two additional Ebola deaths now confirmed in neighboring Liberia, as the disease spreads at an alarming rate.

    On March 5, the Canada-based pharmaceutical company Tekmira announced that its potential Ebola cure now known as TKM-Ebola had received fast-track status from the U.S. Food and Drug Administration. The anti-viral drug has proved to be a cure for Ebola when tested on monkeys infected with the “Zaire strain” of Ebola.

    The highly lethal Zaire strain, researchers believe, is the virus responsible for the current West Africa Ebola outbreak


    Read more at http://www.inquisitr.com/1194812/eb...ead-called-unprecedented/#TjWYUDuPpomBVgLo.99




    Officials Confirm First Ebola Case Diagnosed in the United States

    September 30, 2014

    upload_2014-10-23_12-22-59.png

    A patient being treated at a Dallas hospital has tested positive for Ebola, the first case of the disease to be diagnosed in the United States, federal health officials announced Tuesday.

    Officials at Texas Health Presbyterian Hospital say the unidentified patient is being kept in isolation and that the hospital is following Centers for Disease Control recommendations to keep doctors, staff and patients safe.

    The hospital had announced a day earlier that the patient's symptoms and recent travel indicated a case of Ebola, the virus that has killed more than 3,000 people across West Africa and infected a handful of Americans who have traveled to that region.

    At a press conference Tuesday, Centers for Disease Control director Tom Frieden said the man left Liberia on Sept. 19 and arrived in the United States on Sept. 20. Frieden said the man showed no symptoms immediately upon his return.


    http://www.people.com/article/ebola-first-case-us


    • Texas - Take Note Again


    Tekmira shares soar on contract hopes after first U.S. Ebola case

    Wed Oct 1, 2014 11:43am EDT

    (Reuters) - Tekmira Pharmaceuticals Corp shares jumped as much as 25 percent on Wednesday on hopes the Canadian company could win a U.S. contract for its Ebola drug after the first case of the deadly infection was diagnosed in the United States.

    [​IMG]


    Tekmira is one of several companies developing treatments or vaccines for Ebola. Last month, its experimental drug TKM-Ebola was used on an infected U.S. medical missionary who contracted the virus in Liberia. The man recovered after treatment with the drug and a "convalescent serum" made up of antibodies taken from the blood of a U.S. Ebola survivor.

    Tekmira shares rose as much as 24 percent in Toronto and 25 percent on the Nasdaq, hitting their highest since March. The shares stood at C$28.13 and $25.11, respectively, easing off earlier gains.

    Tekmira's rise outpaced those of other companies developing Ebola drugs, including NewLink Genetics Corp, Sarepta Therapeutics Inc and BioCryst Pharmaceuticals Inc .

    In a research note, RBC analyst Michael Yee said it was possible the U.S. Centers for Disease Control and Prevention (CDC) will use Tekmira's drug to treat the patient diagnosed with Ebola in Dallas. The U.S. Food and Drug Administration has cleared it for use in Ebola patients.

    A man who flew from Liberia to Texas became the first patient infected with Ebola virus to be diagnosed in the United States, health officials said on Tuesday, a sign the outbreak ravaging West Africa may spread globally.

    http://ca.reuters.com/article/idCAL2N0RW0VK20141001?rpc=401






    Now we just need to see how EV-D68 connects to this "Ebola" memorandum that has been given out to the media outlets.

    This is a lot of confusion to go over, but just like any puzzle, it doesn't look like anything connects until you manage to gather most if not all of the pieces.


    Stay woke
     
  6. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Forgot to add this...


    Liberia and Guinea are not party to (have not signed or have not ratified) the BWC Treaty that bans the use and testing of bio-chemical agents on citizens.


    The Biological Weapons Convention (BWC) At A Glance

    The BWC bans:

    • The development, stockpiling, acquisition, retention, and production of:
      1. Biological agents and toxins "of types and in quantities that have no justification for prophylactic, protective or other peaceful purposes;"
      2. Weapons, equipment, and delivery vehicles "designed to use such agents or toxins for hostile purposes or in armed conflict."
    • The transfer of or assistance with acquiring the agents, toxins, weapons, equipment, and delivery vehicles described above.
    The convention further requires states-parties to destroy or divert to peaceful purposes the "agents, toxins, weapons, equipment, and means of delivery" described above within nine months of the convention's entry into force. The BWC does not ban the use of biological and toxin weapons but reaffirms the 1925 Geneva Protocol, which prohibits such use. It also does not ban biodefense programs.


    [​IMG]

    Sources:
    http://www.opbw.org/new_process/msp2007/BWC_MSP_2007_4.pdf
    **Edited to reflect added parties from 2007 report crossed out

    http://www.armscontrol.org/factsheets/bwc


    Other sources:
    http://www.unog.ch/__80256ee6005859...fd5c?OpenDocument&ExpandSection=1,3#_Section1

    http://www.nti.org/treaties-and-reg...riological-biological-and-toxin-weapons-btwc/

    http://www.armscontrol.org/factsheets/bwcsig


    The U.S. is party to the BWC treaty, but not sure if the CDC is party to the U.S. or anybody of government, regardless their patent gives them wiggle room to create and stockpile the new inventions of viruses almost with impunity as they are propped as an agency seeking cures, and for research purposes that aid in those cures or "vaccines".


    Killer cure: why is the US creating new viruses and stockpiling the vaccines?

    April 17, 2013

    Controversial research on bird flu resumes, along with a Bush-era biodefense program

    Is the US government prepared to respond to a major biological weapons attack or lethal outbreak of disease in this country? If you look at one effort — a quietly growing national stockpile of vaccines and drug treatments for such horrors as anthrax and avian flu — the answer is yes. But one agency in charge of building that stockpile is also funding the creation of deadlier and more infectious varieties of avian flu, and other animal-borne diseases, which could pose the threat of an outbreak if not handled properly. The paradox has raised alarm bells among some researchers across the country that the government may be undermining its own biodefense strategy.

    "It reflects the clear lack of anyone in charge."

    "It's hard to imagine that someone thought creating new pandemic pathogens would be a good strategy for defending against pandemic pathogens," said Richard Ebright, a professor of biochemistry at Rutgers University in New Jersey and director of the Waksman Institute of Microbiology, in an interview with The Verge. "It reflects the clear lack of anyone in charge" of US biodefense strategy.

    The seeming disconnect is highlighted by two major developments in national biosecurity that occurred within the last few months. In late February, the US Department of Health and Human Services (HHS) announced that it would restart funding for research projects around the world focused on making new, deadlier, more contagious strains of avian influenza, better known as "bird flu" or "avian flu." Researchers working in this area argue genetically modifying the virus to make it spread more easily in mammals such as humans is "essential for pandemic preparedness," by revealing in advance how the wild virus could potentially mutate. Currently, avian flu doesn't spread easily among mammals or people, and most fatal cases have occurred directly among those people handling or in close proximity to birds. Some researchers have pointed to the recent outbreak of an avian flu strain in China that's killed over a dozen people as evidence of why their work is necessary.

    [​IMG]
    Microscopic image of avian influenza, H5N1 wild type, from Dr. Takeshi Noda, University of Tokyo

    But researchers around the world working to develop new strains temporarily suspended their work voluntarily last year, and the US government followed in halting funding, after a vocal outcry from other scientists that the published results of such research could be weaponized by terrorists, or that new strains could accidentally infect the public. Despite these concerns, the moratorium on research of more infectious bird flu strains ended in January, with researchers saying the "the benefits of this work outweigh the risks." A month later, HHS released a draft version of new funding policies for research, which it said would help minimize the risk to the public, imposing new security criteria on researchers receiving government funds. Still, critics of avian flu research are unswayed.

    "Rather than use the avian flu moratorium to seek advice, listen and foster debate, many influenza scientists engaged in an academic exercise of self-justification," wrote Simon Wain-Hobson, chairman of the nonprofit Foundation for Vaccine Research, in a recent editorial in the journal Nature. "[The moratorium] was strictly for public relations," Ebright agreed, also telling The Verge, "No one with a moral compass would propose or perform this work."

    Source:
    http://www.theverge.com/2013/4/17/4...-vaccine-stockpiling-bird-flu-avian-influenza
     
  7. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Now, follow the bouncing ball...


    Why Everyone Has A Stake In The Chimerix Drug Offered To Josh Hardy


    March 12, 2014

    A small biotechnology company agreed yesterday to provide their experimental, antiviral drug for the treatment of a seven-year-old Virginia boy, Joshua Hardy, who is currently suffering from a life-threatening adenovirus infection acquired during his cancer treatment at St. Jude Children’s Hospital.

    The company, North Carolina-based Chimerix, had originally declined a request by the Hardy family to provide the drug, known as CMX001 or brincidofovir, under the “compassionate use” provision for unapproved drugs.

    In the program known more correctly as “expanded access to investigational drugs outside of a clinical trial,” the FDA permits companies on a case-by-case basis to offer an investigational drug to individuals who have an immediately life-threatening condition where no other therapy currently exists.

    Source:
    http://www.forbes.com/sites/davidkr...g-offered-to-josh-hardy-cmx001-brincidofovir/


    They deny this experimental "anti-viral", and this is what happens...


    Chimerix CEO Out In Wake Of Josh Hardy Compassionate Use Media Frenzy

    April 10, 2014

    A month after brokering a new Phase III trial of Chimerix’s investigational antiviral drug, company CEO Kenneth I. Moch has been replaced and will be pursuing other interests. The company announced yesterday that Moch has been replaced by former chief medical officer of Chimerix, M. Michelle Berrey, MD, MPH.

    Moch had been in the middle of a traditional and social media firestorm when the company denied compassionate use access of their investigational antiviral drug, brincidofovir (CMX001), to 8-year-old Joshua Hardy. The Virginia boy has been suffering from a potentially-fatal adenovirus infection following a bone marrow transplant for his nearly life-long struggle with rhabdoid carcinoma of the kidney.

    John Murawski of the Raleigh News & Observer reported on March 12 that Moch had subsequently received death threats and was placed under armed escort. The 54-person, North Carolina company also required protection, as Murawski then wrote:

    The small drug company’s office was put on lockdown this week as employees feared for their safety, a police sentry stationed at the building’s vestibule and another guarding the third-floor entrance to Chimerix’s headquarters in Durham.

    Following the death threats, Moch told Murawski, ““I’m concerned by the actions of those who really need to look into their own hearts and souls.”


    Source:
    http://www.forbes.com/sites/davidkr...of-josh-hardy-compassionate-use-media-frenzy/


    Still following the bouncing ball??


    Josh Hardy Going Home After Getting Chimerix Anti-Viral Drug


    July 17, 2014

    Social media campaigns for “compassionate use” access to drugs still in clinical trials got a big boost yesterday.

    The mother of Josh Hardy, a now-8-year-old boy suffering with cancer for nearly all of his life, announced on Facebook and the family’s CaringBridge.com website that the boy was going home to Virginia from St. Jude Children’s Hospital, months after receiving an experimental drug for a life-threatening adenovirus infection.

    Josh had developed the viral infection during immunosuppression following a bone marrow transplant. The current standard of therapy, cidofovir, has compromised the boy’s kidney function to the point that the drug had to be withdrawn.

    The family then mounted an aggressive and widely-reported campaign appealing to Chimerix, the small, Durham, North Carolina-based biotechnology company, for access to their anti-viral drug, brincidofovir (CMX001). John Murawski at the Raleigh News & Observer has been doing a bang-up job locally in reporting this story.

    [​IMG]
    Family photo of Josh Hardy at St. Jude Children’s Hospital, Memphis, TN. Credit: Aimee Hardy, Joshua Hardy site at CaringBridge.org

    The Chimerix drug was designed to avoid damaging the kidneys while also being more potent and lasting longer in the body. But the drug was still in phase 3 trials and was being targeted for patients with cytomegalovirus (CMV) infections, although preclinical data were suggestive of its potential efficacy toward other similar double-stranded DNA-based viruses, such as adenoviruses. In fact, the drug had originally be proposed for its potential against a bioterrorism attack with smallpox.


    Source:
    http://www.forbes.com/sites/davidkr...-home-after-getting-chimerix-anti-viral-drug/


    Still keeping up?



    Experimental drug used to treat Ebola patient in Dallas saved Fredericksburg boy Josh Hardy

    October 6, 2014

    RICHMOND, Va. — The experimental drug used to treat Josh Hardy, the Fredericksburg boy stricken with a rare virus, is now being used to treat a man afflicted with Ebola in Texas.

    Despite beating cancer four times, the rare virus attacked’s the 7-year-old’s already compromised immune system, during a life-saving bone marrow transplant.

    As a result, Josh’s parents waged a social media campaign last winter to get their son access to a North Carolina-based drug company’s experimental drug, Brincidofovir.

    Chimerix originally said in March the drug could not be released outside of controlled clinical trials. However, once the drug maker reached an agreement with the FDA, Josh became the first patient of an open-label trial of Brincidofovir. Josh was enrolled as the first patient in the trial on March 12.


    Source:
    http://wtvr.com/2014/10/06/brincidofovir-ebola-drug-treated-josh-hardy/



    Ebola Victim Thomas Eric Duncan Passes Away -- But Not Because Drugs Failed

    October 8, 2014

    While I was finishing my morning post on brincidofovir’s preliminary efficacy in immunocompromised patients with adenoviral infections, the announcement came that Thomas Eric Duncan had succumbed to Ebola Virus Disease in Dallas earlier this morning.

    I’ve been asked for some feedback because Mr. Duncan was reported to have received the Chimerix antiviral drug on Saturday afternoon. Adam Feuerstein at TheStreet just expressed his disgust at the response of stock traders within minutes of the announcement of Mr. Duncan’s death, by driving the stock price of Chimerix down 9% and that of rival Tekmira up 4.7%.

    Adam closes his post with the single word, “Gross.”


    Source:
    http://www.forbes.com/sites/davidkr...bola-victim-passes-away-no-data-just-sadness/


    The Disgusting Reaction to Ebola Patient's Death by Tekmira, Chimerix Traders


    October 8, 2014

    This is pretty disgusting. The ebola patient Thomas Eric Duncan died today and ebola traders rejoice by bidding up shares of Tekmira Pharmaceuticals
    50051ae47d04ee49b81adf6d962e6adb[1].png


    When Duncan's death was announced, Chimerx shares did this:
    0e54a7b88d48cf467f560f0c1719027b[1].png


    Source:
    http://www.thestreet.com/story/1290...atients-death-by-tekmira-chimerx-traders.html



    Does anyone else see something rather peculiar about the first graph that shows the TKMR shares?

    Why did it take a BIG nose dive about 2 hours before it spikes up again?


    Not too keen on how stocks and shares work anymore, but isn't this a sign of "insider information/trading"?


    But look at how fast they get on top of this in Africa!




    Ebola Vaccine Trials: First Doses Of Experimental Treatment Given To Malian Health Workers

    October 9, 2014

    The first trial of an experimental Ebola vaccine has begun in Africa, as three health care workers from Mali infected with the deadly disease that's spreading through the western part of the continent became the first sufferers to receive it. The vaccine, which was developed in the U.S., is expected to be given to another 34 health care workers in the coming weeks.

    2905-vaccine[1].jpg

    "This is just the critical first step in a series of additional clinical trials that will have to be carried out to fully evaluate the promising vaccine," said Professor Samba Sow, director general of the University of Maryland School of Medicine’s Center for Vaccine Development of Mali, in a statement released Thursday. "However, if it is eventually shown to work and if this information can be generated fast enough, it could become a public health tool to bring the current, and future, Ebola virus disease epidemics under control."

    Source:
    http://www.ibtimes.com/ebola-vaccin...treatment-given-malian-health-workers-1702494



    This ties into to the "Ebola Watch" thread based on these "experimental anti-virals" that are to be injected into healthy subjects.

    The incubation time is said to be 21 days, so 21 days later will be October 30 2014...

    Next Thursday... wups, lookie here!



    Mali confirms its first case of Ebola, Health Ministry says

    October 23, 2014

    Bamako, Mali (CNN) -- A 2-year-old girl in Mali has been diagnosed with Ebola, making her the West African country's first confirmed case, health officials said Thursday.

    upload_2014-10-24_13-35-33.png

    The girl was brought to Mali from neighboring Guinea, where the outbreak this year is believed to have started, World Health Organization spokeswoman Yvette Bivigou said.

    The girl, whose father died of Ebola, was taken to the hospital in Kayes after a nurse noticed she was suffering from what appeared to be Ebola-like symptoms. A test confirmed the girl has Ebola, Health Ministry spokeswoman Markatie Daou said.


    Source:
    http://www.cnn.com/2014/10/23/world/africa/ebola-mali/


    Stay woke
     
  8. writer33

    writer33 Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Mar 3, 2014
    Messages:
    209
    Likes Received:
    80
    Gender:
    Male
    Ratings:
    +85
    In my initial post, I mentioned the CIA, its drug trafficking that brought cocaine into the black communities, and the new movie, "Kill the Messenger." More about that in a separate post....
     
Loading...